← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Oral Oncology (ISSN 1879-0593, 1368-8375) is a journal published by Elsevier in the United Kingdom. It covers Biochemistry, Genetics and Molecular Biology, Dentistry and Medicine. It is indexed in Scopus, Web of Science, MEDLINE, PubMed and HEC. Recorded metrics: impact factor 4, Scopus Q1, Web of Science Q1, CiteScore 6.5 and HEC W-Category. Article processing charge: USD 4,500.

Journal title

Oral Oncology

ISSN
1879-0593, 1368-8375
Subject area
BiochemistryGenetics and Molecular BiologyDentistryMedicineOncologyOral SurgeryCancer Research
Indexed
ScopusWeb of ScienceMEDLINEPubMedHEC
Scopus Quartile
Q1
WoS Quartile
Q1
Impact Factor
4
Country
United Kingdom
Publisher
Elsevier
SJR
1.276
Open access
No
APC (USD)
4500
About the journal
A Journal Related to Head & Neck Oncology Oral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck. Oral Oncology is of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngologists, plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields. Basic, translational, or clinical Research or Review papers of high quality and that make a contribution to new knowledge are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue, oral cavity, oropharynx, salivary glands, sinuses, nose, nasopharynx, larynx, skull base, thyroid, and craniofacial region, and the related hard and soft tissues and lymph nodes): • Etiopathogenesis: natural history of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic changes; cellular and molecular changes; microorganisms; growth factors, adhesion and other molecules • Epidemiology; risk factors; biomarkers; protective factors; geographic factors; prevention; screening and intervention • Clinical features; orofacial effects of neoplasms at both local and distant sites; tumor staging and grading • Diagnosis; detection of cancer and pre-cancer; cellular and molecular markers for diagnosis; advances in imaging and other functional diagnostic modalities for cancer and pre-cancer • Management and Prognosis; clinical, cellular and molecular markers for prognosis; treatment options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms of surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics (new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and oral health care. • Quality of life issues; issues of consent; psychosocial aspects; patient and health professional information; patient involvement; psychological interventions, improving outcomes; the prevention, diagnosis and management of complications, including, pain, hemorrhage, dysfunction, deformity, osteoradionecrosis, xerostomia, and others; rehabilitation; palliative and end of life care; and support teamwork.
Aims and Scope
A Journal Related to Head & Neck Oncology Oral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck. Oral Oncology is of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngologists, plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields. Basic, translational, or clinical Research or Review papers of high quality and that make a contribution to new knowledge are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue, oral cavity, oropharynx, salivary glands, sinuses, nose, nasopharynx, larynx, skull base, thyroid, and craniofacial region, and the related hard and soft tissues and lymph nodes): • Etiopathogenesis: natural history of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic changes; cellular and molecular changes; microorganisms; growth factors, adhesion and other molecules • Epidemiology; risk factors; biomarkers; protective factors; geographic factors; prevention; screening and intervention • Clinical features; orofacial effects of neoplasms at both local and distant sites; tumor staging and grading • Diagnosis; detection of cancer and pre-cancer; cellular and molecular markers for diagnosis; advances in imaging and other functional diagnostic modalities for cancer and pre-cancer • Management and Prognosis; clinical, cellular and molecular markers for prognosis; treatment options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms of surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics (new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and oral health care. • Quality of life issues; issues of consent; psychosocial aspects; patient and health professional information; patient involvement; psychological interventions, improving outcomes; the prevention, diagnosis and management of complications, including, pain, hemorrhage, dysfunction, deformity, osteoradionecrosis, xerostomia, and others; rehabilitation; palliative and end of life care; and support teamwork.
SCImago Ranking
3265
HEC
W-Category
Journal Website
www.sciencedirect.com/science/journal/13688375 ↗
Registered In
1996
Instructions for Authors URL
www.sciencedirect.com/journal/oral-oncology/publish/guide-for-authors ↗
Average Time To Publication After Submission (In Weeks)
—
APC Information URL
www.sciencedirect.com/science/journal/13688375/publish/open-access-options ↗
Waiver policy
—
Scopus URL
www.scopus.com/sourceid/12628 ↗
Scopus Cite Score
6.5
WoS Status
Science Citation Index Expanded (SCIE)

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Oral Oncology

Is Oral Oncology HEC recognised?

Yes. The catalogue records Oral Oncology in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Oral Oncology indexed in Scopus?

Yes. Oral Oncology is listed as Scopus-indexed, in quartile Q1, with a CiteScore of 6.5. Check its current status on the Scopus Sources page.

Is Oral Oncology in Web of Science?

Yes. Oral Oncology is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q1. Confirm on Clarivate's Master Journal List.

What is the impact factor of Oral Oncology?

The recorded journal impact factor of Oral Oncology is 4. Clarivate updates impact factors every year in Journal Citation Reports.

Is Oral Oncology open access, and what does it charge?

Oral Oncology is not recorded as fully open access and its APC is USD 4,500. Fees change, so check the journal's website before you submit.

Who publishes Oral Oncology?

Oral Oncology is published by Elsevier in United Kingdom, under ISSN 1879-0593 and 1368-8375.

Research profile

Main research topics: Head and Neck Cancer Studies, Oral Health Pathology and Treatment, Head and Neck Surgical Oncology, Esophageal Cancer Research and Treatment, Oral health in cancer treatment, Salivary Gland Tumors Diagnosis and Treatment.

Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.

Browse similar journals

Find Journal